文献速递糖尿病肥胖与代谢综合征

bFGF通过调控miRNA谱挽救2型糖尿病脂肪干细胞功能

bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile.
PubMed 文献 · Diabetologia · 2025-09-04

本研究探讨碱性成纤维细胞生长因子(bFGF)能否恢复2型糖尿病个体脂肪源性干细胞(ASCs)受损的增殖与迁移能力并改善血管重塑。将糖尿病与非糖尿病个体的ASCs以10 ng/ml bFGF培养9天后进行表型与功能检测,并用miRNA芯片分析差异表达,结合伤口愈合、transwell迁移、共培养及裸鼠Matrigel plug实验评估血管新生。结果显示bFGF显著增强T2DM ASCs的增殖与迁移,改变与增殖相关miRNA表达,并促进HVSMC迁移及管状结构形成;体内实验表明bFGF处理的皮下与内脏T2DM ASCs促进新生血管形成更明显。

要点

  • 10 ng/ml bFGF培养9天可增强T2DM ASCs的增殖与迁移能力。
  • bFGF改变T2DM ASCs中与增殖及血管新生相关的miRNA表达谱。
  • bFGF预处理的T2DM ASCs在体内促进新生血管形成更明显。

核心结论

  • bFGF预处理T2DM ASCs通过改变其miRNA谱增强细胞增殖与血管重塑潜力,可能提高T2DM ASCs的治疗效用。

研究设计与样本

  • 研究纳入有或无糖尿病的个体来源ASCs,以10 ng/ml bFGF培养9天,进行表型与增殖功能检测。
  • 采用miRNA芯片分析处理前后差异表达miRNA,并用伤口愈合、transwell迁移和共培养实验评估ASCs与HVSMC的交互作用。
  • 采用裸鼠Matrigel plug实验评估ASCs对新生血管形成的贡献。

主要发现

  • bFGF处理显著增强T2DM ASCs的增殖和迁移,并改变与ASCs增殖相关miRNA的表达。
  • ASCs促进HVSMC迁移,共培养时促进管状结构形成。
  • 体内Matrigel plug实验显示bFGF处理增强新生血管形成。
  • 非T2DM ASCs与未处理T2DM ASCs均刺激血管生成,而bFGF处理的皮下和内脏T2DM ASCs促进新生血管形成更明显。
  • bFGF处理调控ASCs中多个血管生成相关miRNA的表达。

关键数值与推荐

  • bFGF使用浓度为10 ng/ml,处理时间为9天。

临床怎么用

  • 对T2DM来源ASCs进行bFGF预处理可能作为改善其治疗性血管新生潜力的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The aim of this study was to investigate whether basic fibroblast growth factor (bFGF) can restore the proliferation and migration capacities of adipose-derived stem cells (ASCs), which are impaired by type 2 diabetes, and improve vascular remodelling. METHODS: ASCs obtained from individuals with or without diabetes were cultured with 10 ng/ml bFGF for 9 days. The ASCs were phenotypically characterised and functionally tested for proliferation capacity. Differentially expressed miRNAs before and after treatment were analysed using miRNA arrays. Crosstalk between ASCs and human vascular smooth muscle cells (HVSMCs) was assessed using wound healing, transwell migration and co-culture assays. Finally, a Matrigel plug assay in nude mice was used to evaluate the contribution of ASCs to neovessel formation. RESULTS: bFGF treatment significantly enhanced the proliferation and migration of ASCs from individuals with type 2 diabetes (T2DM ASCs), and altered the expression of miRNAs associated with ASC proliferation. ASCs promoted HVSMC migration and, when co-cultured, facilitated tube-like structure formation. In vivo Matrigel plug assays revealed that bFGF treatment enhanced neovessel formation. Although both non-T2DM ASCs (ASCs from individuals without type 2 diabetes) and untreated T2DM ASCs stimulated angiogenesis, bFGF-treated subcutaneous and visceral T2DM ASCs promoted even greater neovessel formation. Additionally, bFGF treatment modulated the expression of multiple angiogenesis-related miRNAs in ASCs. CONCLUSIONS/INTERPRETATION: Preconditioning T2DM ASCs with bFGF alters their miRNA profile, enhancing cell proliferation and their vascular remodelling potential. This strategy could improve the therapeutic utility of T2DM ASCs.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Civit-Urgell A, Peña E, Bejar MT, et al. bFGF rescues dysfunctional properties of adipose-derived stem cells from individuals with type 2 diabetes by modulating their miRNA profile. Diabetologia. 2025. PMID: 40905998. doi:10.1007/s00125-025-06533-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。